TY  - JOUR

T1  - An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain

JO  - Journal of Bone Oncology

UR  - http://eprints.whiterose.ac.uk/151202/

PY  - 2019/09/18

AU  - Danson S

AU  - Mulvey MR

AU  - Turner L

AU  - Horsman J

AU  - Escott KJ

AU  - Coleman RE

AU  - Ahmedzai SH

AU  - Bennett MI

AU  - Andrew D

ED  - 

DO  - DOI: 10.1016/j.jbo.2019.100261

PB  - Elsevier

Y2  - 2025/01/03

ER  -